Held in past years at the PABC, the Annual Biotechnology Conference this year will be online or virtual, yet interactive. The event is designed especially for leaders of startup and early stage biotech companies.
"Our conference in past years has attracted well over 100 life sciences professionals from around the region," Louis P. Kassa, MPA, executive vice president of the PABC and Blumberg Institute, said. "But, based on the success of the PABC's online Entrepreneur Spotlight in July, which we delivered online, we expect that our conference will attract a larger-than-ever audience from around the country and even overseas.”
The speakers, who are prominent leaders in the Philadelphia region’s pharmaceutical and financial industries, will individually make a presentation followed by a Q&A session with the audience. Below are the speakers.
- Nadia Lovell, U.S. equity strategist, J.P. Morgan Global Wealth Management
- Michele Cleary, PhD, chief executive officer, The Mark Foundation for Cancer Research
- John Maraganore, PhD, chief executive officer, Alnylam Pharmaceuticals
- Eric Freedgood, CPA, CFA, executive vice president, chief innovation officer, senior portfolio manager, Pinnacle Associates.
- Wendy Yeh, MD, senior vice president, clinical research, Vir Biotechnology
This virtual conference is free of charge. Advance registration is required.
About the Pennsylvania Biotechnology Center
The nonprofit Pennsylvania Biotechnology Center (PABC) is one of the nation's most successful life sciences incubators, providing state-of-the-art laboratory and office space to biotech companies and nonprofit research organizations. Managed by the Baruch S. Blumberg Institute and led by a board appointed by the Hepatitis B Foundation, PABC is home to more than 40 small and growing companies in the pharmaceutical and medical device industries. We use a highly successful services-based approach to nurture and guide our member companies to success, as we seek to advance biotechnology, maximize synergies between nonprofit scientists and their commercial colleagues, and launch new ideas and discoveries that will make a difference. With both state and federal grants, the PABC recently began a $19 million expansion of its complex, which will be completed by October 2021. PABC is located near Doylestown in the heart of the pharma belt between North Jersey and Philadelphia. For more, including membership information, visit www.pabiotechbc.org.
About the Baruch S. Blumberg Institute
The Blumberg Institute is a nonprofit research operation that was established in 2003 by the Hepatitis B Foundation. Today it is one of the nation’s leading centers for translational research. The Institute supports drug and biomarker discovery and translational biotechnology around common research themes such as chronic hepatitis B, liver disease and liver cancer in an environment conducive to collaboration. To learn more, visit www.blumberginstitute.org. To donate to the Institute, please click here.